Results 161 to 170 of about 120,918,193 (215)

Pre-pandemic contraction, phase-specific rate variation, and site-specific antigenic adaptation shape influenza A(H3N2) evolutionary dynamics in Hubei, China. [PDF]

J Virol
Peng M, Liu L, Li X, Yu X, Yin Q, Zhang X, Han S, Fang B.   +7 more
europepmc   +1 more source

Vaccine Effectiveness Estimates Against Influenza A(H3N2)-Associated Hospitalized Severe Acute Respiratory Infections in Beijing, China, 2025/26 Influenza Season. [PDF]

Vaccines (Basel)
Ma C, Zhang J, Ma J, Duan W, Wang Y, Hu X, Li J, Zhang L, Di Y, Yan S, Yang P, Wang Q, Shen Y, Zhang D.   +13 more
europepmc   +1 more source

Influenza A(H3N2) Subclade K (J.2.4.1): Molecular Characterization, Antigenic Divergence, and Global Spread During the 2025/26 Season. [PDF]

Infect Dis Rep
Branda F, Petrosillo N, Ceccarelli G, Scarpa F, Giovanetti M, Ciccozzi M.   +5 more
europepmc   +1 more source

Differences in H3N2 and H5N1 influenza.

openaire   +1 more source

FluAttn: Antigenicity prediction of influenza A/H3N2 through attention-based feature mining. [PDF]

Infect Dis Model
Geng L, He J, Liu P.
europepmc   +1 more source

Evolving Dynamics of Whole-Genome Influenza A/H3N2 Viruses Isolated in Cameroon. [PDF]

Adv Virol
Tsafack DT, Monamele CG, Moumbeket-Yifomnjou MH, Messanga Essengue LL, Bilounga CN, Njankouo MR, Touoyem PI, Tamoufe U, Koro FK, Njouom R.   +9 more
europepmc   +1 more source

Modest protection from vaccination against influenza A(H3N2) subclade K, Beijing, China, 2025/26 season. [PDF]

Euro Surveill
Shen Y, Zhang D, Feng Z, Ma C, Shi W, Duan W, Li J, Zhang L, Wu D, Zhang J, Ma J, Wang Y, Hu X, Yan S, Di Y, Zhao J, Xu H, Lu G, Liu Y, Zhang W, Wang Q, Yang P.   +21 more
europepmc   +1 more source

Combinations of Favipiravir with Doxycycline, Azithromycin or Ivermectin Exert Synergistic Effects Against Influenza A H3N2 Virus Replication. [PDF]

Pathogens
Tan KC, Neo JHY, Tran T, Chow VTK.
europepmc   +1 more source

Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A/H3N2 virus. [PDF]

Nat Commun
Hoy G, Cortier T, Maier HE, Kuan G, Lopez R, Sanchez N, Ojeda S, Plazaola M, Stadlbauer D, Shotwell A, Balmaseda A, Krammer F, Cauchemez S, Gordon A.   +13 more
europepmc   +1 more source

Understanding Influenza A(H3N2) Subclade K (J.2.4.1): Asian Epidemiology, Clinical Features, and Public Communication Challenges. [PDF]

Influenza Other Respir Viruses
Hariyanto TI.
europepmc   +1 more source